1. Mizoguchi, K., Hase, A., Obi, T., Matsuoka, H., Takatsu, M., Nishimura, Y., Irie, F., Seyama, Y. and Hirabayashi, Y. (1994) Two species of antiganglioside antibodies in a patient with pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry, 57: 1121–1123.
2. Mujoo, K., Kipps, T.J., Yang, H.M., Cheresh, D.A., Wargalla, U., Sander, D.J. and Reisfeld, R.A. (1989) Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18. Cancer Res., 49: 2857–2861.
3. Ohsawa, T., Miyatake, T. and Yuki, N. (1993) Anti-B-series ganglioside-recognizing autoantibodies in an acute sensory neuropathy patient cause cell death of rat dorsal root ganglion neurons. Neurosci. Lett., 157: 167–170.
4. Roberts, M., Willison, H.J., Vincent, A. and Newsom-Davis, J. (1995) Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann. Neurol., 38: 111–118.
5. Saleh, M.N., Khazaeli, M.B., Wheeler, R.H., Dropcho, E., Liu, T., Urist, M., Miller, D.M, Lawson, S., Dixon, P., Russel, C.H. and LoBuglio, A.F. (1992) Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res., 52: 4342–4347.